Account

Sign in to access your account and subscription

Intellectual Property

  • A steep rise in the use of GenAI and computer-generated influencers brings with it new marketing risks and considerations for celebrities, influencers and businesses alike.

    June 01, 2024Cynthia Cole, Alysha Preston and Inez Asante
  • Licensing inventions vis-a-vis the licensing of patents is not a new practice by any means. However, the explosion of innovation in industries such as technology and pharmaceuticals has placed patent licensing at the forefront of economic advancement.

    June 01, 2024Jose L. Linares, Mark M. Makhail, Stephanie Reed Traband and Michele McGuire Vanderstreet
  • This article describes certain key developments in the period from passage of the CHIPS Act through the present day, and provides a brief survey of key grantmaking and investment activity by U.S. government agencies since passage of the Act.

    May 01, 2024Reid Knabe and Bita Rahebi
  • This article explores the benefits and risks of AI-driven drug discovery from the legal perspective. Since the law governing IP rights in AI-driven drug discovery is still in its infant state, any future legal development is likely to have significant implications in many areas.

    May 01, 2024Fredrick Tsang, Antonia Sequeira and Carl Morales
  • A statutory predicate to the contractual outcome regarding ownership of patent rights is the requirement of a sufficient contribution by a natural person in the effort that yielded the output. The issues implicated by this requirement are one development among more to come as patent law and policy try to catch up to proliferating AI technology.

    May 01, 2024Jim Soong